Pharmacy Innovation
For new clients as well as current clients making benefit changes, our focus is on service excellence to ensure a seamless transition that keeps members on track while supporting... More
Briefing
“Innovation”
41 result(s)
Pharmacy Innovation
For clients transitioning to CVS Health or for current clients making changes to their pharmacy benefit, our focus is on service excellence to ensure we provide a seamless... More
Infographic
Cost Management
The Guaranteed Net Cost model guarantees average net spend per prescription, after discounts and rebates, for each distribution channel. More
Feature
Pharmacy Innovation
The goal of our combined company is to transform the health care experience by building a new innovative health care model that is easier to use, more affordable, and consumer-... More
Video
Cost Management
Lowering Costs for Employees and Members
It's time to bust the myth about drug prices and rebates. Larry Merlo, President and CEO shared CVS Health’s perspective as an employer and PBM in an op-ed. More
Commentary
Cost Management
CVS Health’s real-time benefits helps lower member costs – up to $130 per fill, on average – and provides a better member experience through a streamlined prescribing process. More
Video
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set... More
Commentary
Government Programs and Services
CVS Health undertook an enterprise-wide initiative to ensure 13M Medicare beneficiaries had a smooth transition to new MBI cards. More
Commentary
Cost Management
CVS Health has one of the most comprehensive solutions in the market today, which has proven to save members $120-$130 per fill by making actionable, up-to-the-minute, member-... More
Feature
Cost Management
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker... More
White Paper